Inflammation and the host response to injury, a large-scale collaborative project: Patient-oriented research core-standard operating procedures for clinical care VII-guidelines for antibiotic administration in severely injured patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 65, Issue 6, 2008, Pages 1511-1519

  West, Michael A ^a,i   Moore, Ernest E ^c   Shapiro, Michael B ^b   Nathens, Avery B ^d   Cuschieri, Joseph ^e   Johnson, Jeffrey L ^c   Harbrecht, Brian G ^f   Minei, Joseph P ^g   Bankey, Paul E ^h   Maier, Ronald V ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f University of Louisville School of Medicine   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Antibiotic; Antimicrobial; Bacteria; Bacterial; De escalation; Empiric treatment; Infection; Sepsis; Therapy

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; AZTREONAM; CARBAPENEM; CASPOFUNGIN; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; ERTAPENEM; FLUCONAZOLE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN; VORICONAZOLE; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ACINETOBACTER; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BLOOD CULTURE; BRONCHOSCOPY; CANDIDA; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL VENOUS CATHETERIZATION; CHEST INFECTION; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; DRUG EXPOSURE; EMPYEMA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FUNGAL COLONIZATION; HOSPITAL INFECTION; HUMAN; INFECTION COMPLICATION; INFECTION RISK; INTRACRANIAL PRESSURE MONITORING; LUNG INFECTION; LUNG LAVAGE; MEDICAL CARE; MUSCLE NECROSIS; MYCOSIS; NECROTIZING FASCIITIS; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS; REVIEW; RISK ASSESSMENT; SEPSIS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS INFECTION; SUPERINFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORAX RADIOGRAPHY; TREATMENT RESPONSE; URINALYSIS; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA; VERNER MORRISON SYNDROME; WOUND ASSESSMENT; ALGORITHM; ARTICLE; BACTERIAL INFECTION; CROSS INFECTION; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; INTENSIVE CARE UNIT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTIPLE TRAUMA;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; CROSS INFECTION; DECISION SUPPORT TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVIDENCE-BASED MEDICINE; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; MULTIPLE TRAUMA; SEPSIS;

EID: 67650614690     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318184ee35     Document Type: Review

References (44)

1. Ortiz R, Lee K. Nosocomial infections in neurocritical care. Curr Neurol Neurosci Rep. 2006; 6: 525-530.
2. Jaeger M, Maier D, Kern WV, Sudkamp NP. Antibiotics in trauma and orthopedic surgery-a primer of evidence-based recommendations. Injury. 2006; 37 (Suppl 2): S74-S80.
3. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44: 159-177.
4. Chatterjee I, Iredell JR, Woods M, Lipman J. The implications of enterococci for the intensive care unit. Crit Care Resusc. 2007; 9: 69-75.
5. Merlino JI, Yowler CJ, Malangoni MA. Nosocomial infections adversely affect the outcomes of patients with serious intraabdominal infections. Surg Infect (Larchmt). 2004; 5: 21-27.
6. Lee SY, Kuti JL, Nicolau DP. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance. Surg Infect (Larchmt). 2005; 6: 283-295.
7. Mylotte JM, Goodnough S, Tayara A. Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: retrospective and prospective surveillance. Am J Infect Control. 2001; 29: 139-144.
8. Rohrborn A, Wacha H, Schoffel U, et al. Coverage of enterococci in community acquired secondary peritonitis: results of a randomized trial. Surg Infect. 2000; 1: 95-107.
9. Bohnen JM, Marshall JC, Fry DE, Johnson SB, Solomkin JS. Clinical and scientific importance of source control in abdominal infections: summary of a symposium. Can J Surg. 1999; 42: 122-126.
10. Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidencebased review. Crit Care Med. 2004; 32(11 Suppl): S513-S526.
11. Marshall JC. Intra-abdominal infections. Microbes Infect. 2004; 6: 1015-1025.
12. Danielson D, West MA. Recent developments in clinical management of surgical sepsis. Curr Opin Crit Care. 2001; 7: 367-370.
13. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36: 296-327.
14. Minei JP, Nathens AB, West M, et al. Inflammation and the Host Response to Injury, a Large-Scale Collaborative Project: patientoriented research core-standard operating procedures for clinical care. II. Guidelines for prevention, diagnosis and treatment of ventilator-associated pneumonia (VAP) in the trauma patient. J Trauma. 2006; 60: 1106-1113, discussion 1113.
15. Kollef MH. Treatment of ventilator-associated pneumonia: get it right from the start. Crit Care Med. 2003; 31: 969-970.
16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101: 1644-1655.
17. Muckart DJ, Bhagwanjee S. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med. 1997; 25: 1789-1795.
18. Sprung CL, Sakr Y, Vincent JL, et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Intensive Care Med. 2006; 32: 421-427.
19. Cohen J, Brun-Buisson C, Torres A, Jorgensen J. Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med. 2004; 32 (11 Suppl): S466-S494.
20. McGilvray ID, Rotstein OD. Management of infection in the surgical patient: an update. Surg Technol Int. 2003; 11: 39-43.
21. Nathens AB. Relevance and utility of peritoneal cultures in patients with peritonitis. Surg Infect (Larchmt). 2001; 2: 153-160; discussion 160-162.
22. Bochud PY, Bonten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004; 32 (11 Suppl): S495-S512.
23. Malangoni MA, Song J, Herrington J, Choudhri S, Pertel P. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg. 2006; 244: 204-211.
24. Bradford PA, Weaver-Sands DT, Petersen PJ. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections. Clin Infect Dis. 2005; 41 (Suppl 5): S315-S332.
25. Bartlett JG, Onderdonk AB, Louie T, et al. A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg. 1978; 113: 853-857.
26. Mosdell DM, Morris DM, Voltura A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 1991; 214: 543-549.
27. Mazuski JE, Sawyer RG, Nathens AB, et al. The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: an executive summary. Surg Infect. 2002; 3: 161-173.
28. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003; 37: 997-1005.
29. Smith RL II, Sawyer RG, Pruett TL. Hospital-acquired infections in the surgical intensive care: epidemiology and prevention. Zentralbl Chir. 2003; 128: 1047-1061.
30. Shorr AF, Kollef MH. Ventilator-associated pneumonia: insights from recent clinical trials. Chest. 2005; 128 (5 Suppl 2): 583S-591S.
31. Niederman MS. De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care. 2006; 12: 452-457.
32. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171: 388-416.
33. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003; 290: 2588-2598.
34. Wunderink RG, Rello J, Cammarata SK, Cross-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003; 124: 1789-1797.
35. National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control. 2002; 30: 458-475.
36. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999; 27: 887-892.
37. Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs. 2003; 63: 1459-1480.
38. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004; 53 (Suppl 2): ii37-ii50.
39. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32: 1249-1272.
40. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004; 32: 2014-2020.
41. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Hammond JM, Hendrix CW. The diagnostic value of fungal surveillance cultures in critically ill patients. Surg Infect. 2000; 1: 273-281.
42. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med. 2005; 31: 1479-1487.
43. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebocontrolled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001; 233: 542-548.
44. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007; 142: 624-631; discussion 631.